Abstract

The abscopal effect following ionizing radiation therapy (RT) is considered to be a rare event. This effect does occur more frequently when combined with other therapies, including immunotherapy. Here we demonstrate that the frequency of abscopal events following RT alone is highly dependent upon the degree of adrenergic stress in the tumor-bearing host. Using a combination of physiologic, pharmacologic and genetic strategies, we observe improvements in the control of both irradiated and non-irradiated distant tumors, including metastatic tumors, when adrenergic stress or signaling through β-adrenergic receptor is reduced. Further, we observe cellular and molecular evidence of improved, antigen-specific, anti-tumor immune responses which also depend upon T cell egress from draining lymph nodes. These data suggest that blockade of β2 adrenergic stress signaling could be a useful, safe, and feasible strategy to improve efficacy in cancer patients undergoing radiation therapy.

Highlights

  • The abscopal effect following ionizing radiation therapy (RT) is considered to be a rare event

  • We previously reported that the standard cool housing temperature mandated for laboratory mice accelerates tumor growth and metastasis and suppresses anti-tumor immunity by subjecting mice to chronic adrenergic stress[28,29]

  • We began by testing whether the efficacy of ionizing radiation and, the abscopal effect[5,8,38], is influenced by the physiological stress induced by housing mice at the standard (IACUC-mandated) housing temperature

Read more

Summary

Introduction

The abscopal effect following ionizing radiation therapy (RT) is considered to be a rare event. That this abscopal effect is mediated by immune activity is supported by the presence of an increased number of intratumoral CD8+ T cells, especially CD8+ effector/memory T cells (Supplementary Fig. 1c middle and right) in the contralateral, non-irradiated tumors of mice housed at TT.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.